Discovery and Structural Characterization of ATP-Site Ligands for the Wild-Type and V617F Mutant JAK2 Pseudokinase Domain.
McNally, R., Li, Q., Li, K., Dekker, C., Vangrevelinghe, E., Jones, M., Chene, P., Machauer, R., Radimerski, T., Eck, M.J.(2019) ACS Chem Biol 14: 587-593
- PubMed: 30763067 
- DOI: 10.1021/acschembio.8b00722
- Primary Citation of Related Structures:  
6G3C, 6D2I, 5WIJ, 5WIL, 5WIK, 5WIN, 5WIM - PubMed Abstract: 
The oncogenic V617F mutation lies in the pseudokinase domain of JAK2, marking it as a potential target for development of compounds that might inhibit the pathogenic activity of the mutant protein. We used differential scanning fluorimetry to identif ...